pancreatic cancer
The firms launched the global Phase II bladder cancer trial for autogene cevumeran after seeing early success in pancreatic cancer.
The trial aims to enroll 40 patients with FGFR alterations across the US, who won't need to travel far to receive care.
Nanobiotix Radio Enhancer Could Help Target Radiotherapy in Pancreatic Cancer Patients, Study Shows
Premium
The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.
Personalized Neoantigen Vaccine Shows Feasibility but Limited Efficacy in MSS Colorectal Cancer
Premium
Researchers at AACR's annual meeting said they hope the vaccine will show stronger efficacy in patients with minimal residual disease.
The model combines estimates of skeletal muscle with routinely collected clinical data and unstructured notes and predicts the individual likelihood of cachexia.
Mar 13, 2025